Diagnostic and therapeutic advances in neuroendocrine tumours

Nat Rev Endocrinol. 2021 Feb;17(2):81-82. doi: 10.1038/s41574-020-00458-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Molecular Diagnostic Techniques
  • Neoplasm Grading
  • Neuroendocrine Tumors / diagnosis*
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / therapy*
  • Octreotide / analogs & derivatives
  • Octreotide / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals / therapeutic use*
  • Response Evaluation Criteria in Solid Tumors
  • Somatostatin / analogs & derivatives*
  • Surgical Procedures, Operative

Substances

  • Biomarkers, Tumor
  • Immune Checkpoint Inhibitors
  • Organometallic Compounds
  • Radiopharmaceuticals
  • Somatostatin
  • lutetium Lu 177 dotatate
  • Octreotide